Veeva Systems (NYSE:VEEV) Stock Crosses Below 50-Day Moving Average - Here's What Happened

Veeva Systems logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Veeva Systems shares fell below their 50-day moving average of $292.50, trading as low as $288.08 and last at $288.73.
  • Analysts maintain a Moderate Buy consensus with an average price target of $317.42; 19 analysts rate the stock Buy, eight Hold, and one Sell.
  • The company beat quarterly earnings and revenue estimates, reporting $2.35 per share and $927.96 million in revenue; revenue increased 17.6% year over year.
  • Five stocks to consider instead of Veeva Systems.

Veeva Systems Inc. (NYSE:VEEV - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $292.50 and traded as low as $288.08. Veeva Systems shares last traded at $288.7310, with a volume of 1,238,304 shares trading hands.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on VEEV. JPMorgan Chase & Co. lifted their target price on Veeva Systems from $272.00 to $299.00 in a research note on Thursday, August 27th. Weiss Ratings upgraded shares of Veeva Systems from a "hold (c)" rating to a "hold (c+)" rating in a research report on Thursday, October 8th. Oppenheimer restated an "outperform" rating and set a $325.00 price objective (up from $300.00) on shares of Veeva Systems in a report on Thursday, October 15th. Mizuho set a $345.00 price objective on shares of Veeva Systems in a research report on Thursday, October 29th. Finally, Royal Bank Of Canada lifted their price objective on shares of Veeva Systems from $325.00 to $365.00 and gave the stock an "outperform" rating in a research report on Friday, November 6th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Veeva Systems has a consensus rating of "Moderate Buy" and an average price target of $317.42.

Read Our Latest Stock Analysis on VEEV

Veeva Systems Price Performance

The stock has a market capitalization of $46.75 billion, a P/E ratio of 47.49, a price-to-earnings-growth ratio of 1.28 and a beta of 0.89. The company has a 50 day simple moving average of $292.50 and a 200-day simple moving average of $214.82.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.23 by $0.12. The firm had revenue of $927.96 million for the quarter, compared to analysts' expectations of $905.38 million. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The business's revenue for the quarter was up 17.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, equities analysts forecast that Veeva Systems Inc. will post 6.70 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Daniel Rizzo sold 4,841 shares of the stock in a transaction dated Friday, October 2nd. The stock was sold at an average price of $276.51, for a total transaction of $1,338,584.91. Following the sale, the executive vice president owned 7,665 shares of the company's stock, valued at approximately $2,119,449.15. This represents a 38.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Thomas Schwenger sold 10,000 shares of the stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the completion of the sale, the insider directly owned 19,449 shares in the company, valued at approximately $5,471,587.17. The trade was a 33.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 20,789 shares of company stock valued at $5,905,609. 10.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On Veeva Systems

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Aberdeen Group plc raised its position in shares of Veeva Systems by 1,513.8% in the 3rd quarter. Aberdeen Group plc now owns 2,029,943 shares of the technology company's stock worth $579,447,000 after acquiring an additional 1,904,153 shares in the last quarter. Fundsmith LLP bought a new position in shares of Veeva Systems during the second quarter valued at approximately $144,955,000. Arrowstreet Capital Limited Partnership increased its position in Veeva Systems by 203.0% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company's stock valued at $160,427,000 after buying an additional 611,868 shares in the last quarter. Pacer Advisors Inc. raised its position in shares of Veeva Systems by 757.5% in the 1st quarter. Pacer Advisors Inc. now owns 485,046 shares of the technology company's stock worth $85,203,000 after purchasing an additional 428,478 shares during the last quarter. Finally, Ashe Capital Management LP bought a new position in shares of Veeva Systems in the second quarter worth approximately $75,232,550. Hedge funds and other institutional investors own 88.20% of the company's stock.

About Veeva Systems

(Get Free Report)

Veeva Systems Inc. develops cloud-based software, data and consulting services for the life sciences industry. Its customers include pharmaceutical and biotechnology companies, medical device makers and contract research organizations. The company's products support commercial operations as well as clinical, regulatory, quality and safety activities. Its offerings include Veeva Vault applications for managing documents and business processes, customer relationship management software, and data and analytics services.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines